Western blot analysis of mPR gamma expression in HUVEC (A) whole cell lysates.
MPRG / PAQR5 Antibody (C-Terminus)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunocytochemistry, Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human, Mouse, Sheep |
| Format: | Liquid |
$272.00each
Catalog Number: LS-C413057-30
Catalog Number: LS-C413057
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- PAQR5 antibody LS-C413057 is an unconjugated rabbit polyclonal antibody to PAQR5 (MPRG) (C-Terminus) from human. It is reactive with human, mouse and sheep. Validated for ICC, IF, IHC and WB. Cited in 1 publication.
- Application
- ICC, IF, IHC, IHC-P, WB
- Reactivity
- Hu, Ms, Sh
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- MPR gamma | PAQR5 | MPRG
- Recommended Dilution: IF/ICC
- 1:100 - 1:500
- Recommended Dilution: IHC-P
- 1:100 - 1:200
- Recommended Dilution: WB
- 1:500 - 1:1000
- UniProt Number
- Q9NXK6
- NCBI GenBank
- NM_017705 | NP_060175.3
- SwissProt
- Q9NXK6
Target
- Target
- Human MPRG / PAQR5
- Antigen Species
- Human
- Epitope
- Recognizes endogenous levels of mPR gamma protein.
- Gene Name
- PAQR5
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the C-Terminus of human mPR gamma.
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.3, 0.01% Sodium Azide, 30% Glycerol
- Volume
- 30 Microliter
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Aliquot and store at -20°C for 1 year. Avoid freeze/thaw cycles.
- Recommended Storage Buffer
- PBS
PAQR5 Expression Is Suppressed by TGFß1 and Associated With a Poor Survival Outcome in Renal Clear Cell Carcinoma. Chang Tao, Wang Liu, Xiang Yan, Min Yang, Si Yao, Qiang Shu, Benyi Li, Runzhi Zhu. Frontiers in oncology. 2022 February;11:827344. PubMed: 35127538 PMC: PMC8810503